Deep Genomics at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Deep Genomics at ASHG 2026 in Montréal: 2 presentations (1 lightning talk, 1 poster).

Organization	ASHG 2026 Attendance
Deep Genomics Cleveland, Ohio	1 Research Scientist in statistical genetics
deepgenomics.com\|LinkedIn ~100 people Deep Genomics develops AI-driven genetic medicines using biological foundation models for molecular design and target biology discovery. It supports pharmaceutical partners. Deep Genomics appointed Thong Q. Le as chair of its board of directors, a new leadership contact. › Deep Genomics appointed Thong Q. Le as chair of its board of directors, a new leadership contact. 2026-07 · source Deep Genomics added Thong Q. Le and Paul Sekhri to its board, bringing in experienced business leaders. 2025-10 · source Deep Genomics expanded REPRESS, its RNA biology foundation-model platform, adding new capabilities for genetic medicine design. 2025-05 · source Source: company newsroom Raised $180M Series C (Jul 2021) › Led by SoftBank Vision Fund 2; the most recent disclosed financing round for the company. · 2021-07-28 “closing of a $180 million Series C financing round. SoftBank Vision Fund 2 led the financing.” Source: funding announcement Currently hiring: 3 open roles › Source: careers page	Talk Wed Oct 21 1:30 pm Part of Advancing Precision Oncology with AI, Functional Genomics, and Multi-Omics: From Risk Prediction to Tumor Evolution and Therapeutic Discovery Mendelian randomization using genomic foundation models improves discovery power over additive QTLs and prioritizes cell-type specific therapeutic targets Room 510/Level 5 Identification of disease genesLarge-scale biobanksMendelian randomizationArtificial intelligence Poster Fri Oct 23 2:30 pm ★ Reviewers’ Choice Part of Artificial Intelligence and Machine Learning Poster Friday Session Mendelian randomization using genomic foundation models improves discovery power over additive QTLs and prioritizes cell-type specific therapeutic targets Exhibit & Poster Hall · Board 8082F Artificial intelligenceIdentification of disease genesLarge-scale biobanksMendelian randomization

Organization

ASHG 2026 Attendance

Deep Genomics

Cleveland, Ohio

1 Research Scientist in statistical genetics

deepgenomics.com|LinkedIn

~100 people

Deep Genomics develops AI-driven genetic medicines using biological foundation models for molecular design and target biology discovery. It supports pharmaceutical partners.

Deep Genomics appointed Thong Q. Le as chair of its board of directors, a new leadership contact.

›

Deep Genomics appointed Thong Q. Le as chair of its board of directors, a new leadership contact.

2026-07 · source

Deep Genomics added Thong Q. Le and Paul Sekhri to its board, bringing in experienced business leaders.

2025-10 · source

Deep Genomics expanded REPRESS, its RNA biology foundation-model platform, adding new capabilities for genetic medicine design.

2025-05 · source

Source: company newsroom

Raised $180M Series C (Jul 2021)

›

Led by SoftBank Vision Fund 2; the most recent disclosed financing round for the company. · 2021-07-28

“closing of a $180 million Series C financing round. SoftBank Vision Fund 2 led the financing.”

Source: funding announcement

Currently hiring: 3 open roles

›

Source: careers page

Talk

Wed Oct 21
1:30 pm

Part of Advancing Precision Oncology with AI, Functional Genomics, and Multi-Omics: From Risk Prediction to Tumor Evolution and Therapeutic Discovery

Mendelian randomization using genomic foundation models improves discovery power over additive QTLs and prioritizes cell-type specific therapeutic targets

Room 510/Level 5

Identification of disease genesLarge-scale biobanksMendelian randomizationArtificial intelligence

Poster

Fri Oct 23
2:30 pm

★ Reviewers’ Choice

Part of Artificial Intelligence and Machine Learning Poster Friday Session

Mendelian randomization using genomic foundation models improves discovery power over additive QTLs and prioritizes cell-type specific therapeutic targets

Exhibit & Poster Hall · Board 8082F

Artificial intelligenceIdentification of disease genesLarge-scale biobanksMendelian randomization

Instantly find 20 buyers from Deep Genomics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction